Resilience-Building Intervention for Aging Individuals with HIV
(RISE+ Trial)
Trial Summary
What is the purpose of this trial?
This study will examine the mechanisms and efficacy of a resilience building intervention in older people living with HIV.
Eligibility Criteria
This trial is for people over 50 with HIV who are patients at the UAB HIV Clinic. They should have had some trouble managing their HIV in the last year, like missing a clinic visit or having a detectable viral load. People with serious mental health conditions like schizophrenia, bipolar disorder, or major depression cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a baseline assessment including a 14-day experience sampling method (ESM) protocol
Treatment
Participants attend four weekly two-hour group sessions, either in the RISE+ Resilience Intervention or Stress Reduction Control group
Post-Intervention Assessment
Participants complete a one-month post-intervention assessment including qualitative and quantitative feedback and a second ESM protocol
Follow-up
A three-month follow-up to assess health outcomes, including HIV treatment management abilities, health-related quality of life, depressive symptoms, HIV viral load, and medication adherence
Treatment Details
Interventions
- RISE+
- Stress Reduction Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
National Institute on Aging (NIA)
Collaborator